X

Trial Profile

The Role of Prostaglandins in the Progression of Diabetic Retinopathy and the Therapeutic Efficacy of Topical Ketorolac (Acuvail)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ketorolac (Primary)
Indications Diabetic retinopathy; Retinal disorders
Focus Pharmacodynamics

Most Recent Events

20 Feb 2017 Status changed from recruiting to withdrawn prior to enrolment.
08 Dec 2015 Planned End Date changed from 1 Jan 2016 to 1 Dec 2016, as reported by ClinicalTrials.gov.
07 Jan 2014 Planned End Date changed from 1 Mar 2013 to 1 Jan 2016 as reported by clinicalTrials.gov

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com